Estimaciones de analistas de Wall Street para Legend Biotech Corporation (LEGN): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-11 | $0.02 | ||
| 2026-08-11 | $0.09 | $0.12 | -25.0% |
| 2026-05-12 | $-0.15 | $-0.02 | -650.0% |
| 2026-03-10 | $-0.08 | $-0.17 | +52.9% |
| 2025-11-12 | $-0.11 | $-0.13 | +15.4% |
| 2025-08-11 | $-0.34 | $-0.11 | -199.7% |
| 2025-05-13 | $-0.07 | $-0.23 | +69.0% |
| 2025-03-11 | $-0.15 | $-0.25 | +39.5% |
Ratios de valoración
| Precio / Valor contable | 2.57 |
| EV / EBITDA | -396.64 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $23.6M | $49.1M | $61.8M | $75.0M | $68.8M | $117.0M | $285.1M | $627.2M | $1.03B |
| Coste de Ventas | -$96000 | 0 | 0 | 0 | 0 | $65.4M | $144.2M | $234.6M | $408.1M |
| Beneficio Bruto | $23.7M | $49.1M | $61.8M | $75.0M | $68.8M | $51.6M | $140.9M | $392.7M | $620.8M |
| I+D | $8.2M | $60.6M | $161.9M | $232.2M | $313.3M | $335.6M | $382.2M | $413.5M | $414.7M |
| Generales y Administrativos | $1.4M | $3.9M | $32.4M | $72.7M | $149.5M | $174.0M | $200.9M | $284.3M | $341.6M |
| Gastos Operativos | $9.6M | $64.2M | $194.3M | $75.0M | $461.1M | $507.3M | $580.4M | $695.9M | $757.3M |
| Beneficio Operativo | $13.8M | -$1.5M | -$132.5M | 0 | -$392.3M | -$455.6M | -$439.5M | -$303.2M | -$136.5M |
| EBITDA | $14.1M | $149000 | -$129.4M | -$298.2M | -$392.4M | -$416.5M | -$477.9M | -$113.2M | -$232.3M |
| Gastos por Intereses | 0 | $82000 | $223000 | $4.2M | $900000 | $10.8M | $21.8M | $21.6M | $21.4M |
| Beneficio Antes de Impuestos | $13.8M | -$1.6M | -$127.3M | -$308.3M | -$407.2M | -$445.7M | -$520.1M | -$158.1M | -$282.6M |
| Impuestos | $4.5M | $1.2M | -$25.7M | -$41.9M | -$3.6M | $625000 | -$1.9M | $18.9M | $14.2M |
| Beneficio Neto | $9.4M | -$2.8M | -$101.6M | -$266.4M | -$403.6M | -$446.3M | -$518.3M | -$177.0M | -$296.8M |
| BPA | $0.07 | $-0.03 | $-1.01 | $-2.57 | $-2.74 | $-2.81 | $-2.94 | $-0.97 | $-1.60 |
| BPA Diluido | $0.07 | $-0.03 | $-1.01 | $-2.57 | $-2.74 | $-2.81 | $-2.94 | $-0.97 | $-1.60 |
| Acciones en Circulación (Diluidas) | $132.0M | $100.2M | $132.0M | $118.2M | $140.9M | $159.0M | $176.1M | $182.9M | $184.3M |
Precio
| Precio | $17.00 |
| Capitalización | $3.1B |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: AAPG · ADPT · CELC · CGON · IDYA · IRON · SRRK
Explorar sector: Healthcare · Biotechnology
Más secciones de LEGN: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones